Now showing 1 - 10 of 22
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Systematic review, methodological appraisal, and recommendation mapping of clinical practice guidelines for managing patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
    (Informa UK Limited, 2025-02-26)
    Mohammed AlFada
    ;
    Hend Alotaibi
    ;
    Sahar Alsharif
    ;
    Ahmad Hecham Alani
    ;
    Andrea Andrade-Miranda
    Purpose: The Appraisal of Guidelines for Research and Evaluation II Instrument (AGREE II) was developed to enhance the methodological rigor of clinical practice guidelines (CPGs), aiming to generate trustworthy recommendations for various clinical scenarios. Despite its importance, there exists a gap in the quality of CPGs pertaining to Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis (SJS-TEN). The aim of the study was to evaluate SJS-TEN CPGs to shed light on areas for enhancing SJS-TEN guidelines’ quality. Materials and methods: A systematic review was conducted to identify SJS-TEN CPGs from January 2011 to December 2023 across bibliographic and guideline databases, as well as dermatology association websites. Four reviewers employed the AGREE II instrument to appraise the quality of eligible CPGs. Subsequently, AGREE II domain scores were calculated and their recommendations mapped. Results and Conclusions: Seven eligible SJS-TEN CPGs reviewed, originating from Europe, North America, Asia, and an authorship Group. The highest AGREE II domain scores were observed in scope and purpose (mean: 63%, standard deviation [SD]: 23.195%) and clarity of presentation (mean: 70%, SD: 14.5%). Conversely, the lowest score was noted in the applicability domain (mean: 28%, SD: 17.44%). Only two guidelines by the British Association of Dermatologists (28.6%) met the ‘recommend’ level. Recommendations from all CPGs were compared in tabular form.
    Scopus© Citations 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Using evidence to decision frameworks led to guidelines of better quality and more credible and transparent recommendations
    (Elsevier BV, 2023-10)
    Jose F. Meneses-Echavez
    ;
    Julia Bidonde
    ;
    ;
    Yasser S. Amer
    ;
    Andres Felipe Loaiza-Betancur
    Scopus© Citations 13
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Scopus© Citations 6
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Quality assessment of Clinical Practice Guidelines (CPG) for the diagnosis and treatment of inflammatory bowel disease using the AGREE II instrument: a systematic review
    (Springer Science and Business Media LLC, 2022-11-05)
    R. Zambrano-Sánchez
    ;
    P. Alvarez-Mena
    ;
    D. Hidalgo
    ;
    C. M. Escobar Liquitay
    ;
    J. V. A. Franco
    <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>The incidence and diagnosis of inflammatory bowel disease (IBD) has increased considerably in recent years. Many clinical practice guidelines (CPG) have been developed for the management of this disease across different clinical contexts, however, little evidence exists on their methodological quality. Therefore, we aimed to systematically evaluate the quality of CPGs for the diagnosis and treatment of IBD using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>We identified CPGs by searching databases (MEDLINE - PubMed, EMBASE, CINAHL, LILACS) and other sources of gray literature on January 2022. We included guidelines with specific recommendations for the diagnosis and treatment of IBD and evaluated them with the AGREE II instrument to assess their methodological quality. Six independent reviewers assessed the quality of the guidelines and resolved conflicts by consensus. We assessed the degree of agreement using the intraclass correlation coefficient (ICC) and change in quality over time was appraised in two periods: from 2012 to 2017 and from 2018 to 2022.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>We analyzed and evaluated 26 CPGs that met the inclusion criteria. The overall agreement among reviewers was moderate (ICC: 0.74; 95% CI 0.36 - 0.89). The mean scores of the AGREE II domains were: “Scope and purpose” 84.51%, “Stakeholder involvement” 60.90%, “Rigor of development” 69.95%, “Clarity of presentation” 85.58%, “Applicability” 26.60%, and “Editorial independence” 62.02%. No changes in quality were found over time.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>The quality of the CPGs evaluated was generally good, with a large majority of the assessed guidelines being “recommended” and “recommended with modifications”; despite this, there is still room for improvement, especially in terms of stakeholder involvement and applicability. Efforts to develop high quality CPGs for IBD need to be further optimized.</jats:p> </jats:sec>
    Scopus© Citations 6
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Scopus© Citations 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Scopus© Citations 6
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The impact of indoor pollution on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma
    (Wiley, 2024-02-17)
    Ioana Agache
    ;
    Carlos Canelo‐Aybar
    ;
    Isabella Annesi‐Maesano
    ;
    Lorenzo Cecchi
    ;
    Benedetta Biagioni
    Abstract Systematic review using GRADE of the impact of exposure to volatile organic compounds (VOCs), cleaning agents, mould/damp, pesticides on the risk of (i) new‐onset asthma (incidence) and (ii) adverse asthma‐related outcomes (impact). MEDLINE, EMBASE and Web of Science were searched for indoor pollutant exposure studies reporting on new‐onset asthma and critical and important asthma‐related outcomes. Ninety four studies were included: 11 for VOCs (7 for incidenceand 4 for impact), 25 for cleaning agents (7 for incidenceand 8 for impact), 48 for damp/mould (26 for incidence and 22 for impact) and 10 for pesticides (8 for incidence and 2 for impact). Exposure to damp/mould increases the risk of new‐onset wheeze (moderate certainty evidence). Exposure to cleaning agents may be associated with a higher risk of new‐onset asthma and with asthma severity (low level of certainty). Exposure to pesticides and VOCs may increase the risk of new‐onset asthma (very low certainty evidence). The impact on asthma‐related outcomes of all major indoor pollutants is uncertain. As the level of certainty is low or very low for most of the available evidence on the impact of indoor pollutants on asthma‐related outcomes more rigorous research in the field is warranted.
    Scopus© Citations 54
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Quality and Bias in Randomized Controlled Trials Published in Latin American Nursing Journals: A Meta‐Epidemiological Study
    (Wiley, 2025-09-24)
    Diana Buitrago García
    ;
    Melixa Medina‐Aedo
    ;
    ;
    Wendy Rodriguez Vargas
    ;
    Mónica Lozano Hernández
    Introduction: Randomized controlled trials (RCTs) are essential for evidence‐based nursing care. However, the quality of reporting and adherence to methodological standards in Latin American nursing journals remains unclear. This study evaluates the characteristics, reporting quality, and potential risk of bias of RCTs published in Latin American nursing journals. Objective: To assess the reporting compliance and risk of bias of RCTs published in Latin American nursing journals. Design: Meta‐research study. Methods: A comprehensive handsearch of 29 Latin American nursing journals was performed covering publications from 2000 to 2024. Identified RCTs were assessed for adherence to CONSORT reporting guidelines and evaluated for risk of bias. Outcomes were classified using the COMET taxonomy. A descriptive analysis was performed. Results: A total of 6377 references were screened, identifying 34 eligible RCTs, most published after 2018. The median CONSORT compliance was 19 reported items (IQR 16–22). High compliance (&gt; 90%) was observed in abstract reporting items, study objectives, and participant selection criteria. However, critical methodological features such as randomization procedures, blinding, and protocol registration showed low adherence (&lt; 40%). Risk of bias was mostly rated as having “some concerns”, largely due to insufficient reporting. According to the COMET taxonomy, the most frequently reported outcome domains were “Delivery of care” and “Physical functioning”. Conclusions: Reporting compliance and risk of bias of RCTs published in Latin American nursing journals presents significant gaps, particularly in key methodological domains. These shortcomings hinder transparency, reproducibility, and integration into evidence synthesis. Strengthening editorial policies and enforcing reporting standards could enhance the quality and reliability of published research in Latin American nursing journals.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Predicting early response to ablative radiotherapy in oligometastatic disease: a scoping review of radiomics-based machine learning and deep learning models
    (Springer Science and Business Media LLC, 2026-04-30)
    García-Pablo, Raquel
    ;
    Canela-Capdevila, Marta
    ;
    Martínez-Caballero, Alberto
    ;
    Benavides-Villareal, Rocío
    ;
    Moragas-Fernández, Albert
    Objectives Oligometastatic disease represents an intermediate stage of cancer, often treated with surgery or ablative radiotherapy (ART). This scoping review aimed to systematically summarize current evidence on the use of radiomics, including machine learning and deep learning approaches, to predict response to ART. We also aimed to assess the methodological quality and reporting transparency of published studies, identifying gaps and opportunities for future research. Materials and methods A systematic search in PubMed, Web of Science, Scopus, Embase, Cochrane, and Google Scholar identified studies that used radiomics for predicting ART response. Two reviewers independently selected and assessed the methodological quality using the Radiomics Quality Score (RQS) and the METhodological RadiomICs Score (METRICS). In addition, reporting transparency was evaluated using the CheckList for EvaluAtion of Radiomics research (CLEAR). This scoping review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for Scoping Reviews guidelines. Results The systematic search identified 9463 records, of which 29 studies (3946 patients) were included. Most studies used MRI-derived features, with 24 focusing on brain metastases. Radiomics-based models demonstrated variable predictive performance (area under the curve, AUC: 0.69–0.95), with deep learning models achieving the highest accuracies (AUC: 0.85–1.00). Methodological quality of the studies was moderate (mean RQS: 13; METRICS: 64.2–78%). Conclusion Radiomics-based models show potential for identifying patients unlikely to benefit from ART, but their clinical implementation remains limited, especially for extracranial metastases. Future research should focus on multicenter, prospective studies with standardized protocols, incorporating clinical and dosimetric data for broader clinical application. Key Points Question Can radiomics-based predictive models reliably assess treatment response to ablative radiotherapy in oligometastatic disease, and how robust is the current methodological evidence supporting their use? Findings Radiomics models show encouraging predictive performance, mainly for brain metastases, yet substantial methodological heterogeneity and limited validation hinder their clinical translation. Clinical relevance Radiomics-based prediction models hold potential for identifying patients unlikely to benefit from ablative radiotherapy, enabling more personalized treatment. Further prospective, multicenter, and methodologically standardized studies are essential before clinical implementation.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations
    (Elsevier BV, 2022-10)
    Jose F. Meneses-Echavez
    ;
    Julia Bidonde
    ;
    Juan Jose Yepes-Nuñez
    ;
    Tina Poklepović Peričić
    ;
    Livia Puljak
    Scopus© Citations 28